© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Elevance Health Inc. (ELV) shows an Average True Range (ATR) of 9.83 and an Enterprise Value of 144.27B. Its average trading volume over the past 3 months is 1.7M, indicating liquidity. These fundamental metrics provide insight into ELV's underlying financial health and market activity.
Elevance Health Inc. (ELV) technical indicators as of December 22, 2025: the SMA 20 is 0.43%, SMA 50 at 1.71%, and SMA 200 at -4.4%. The RSI 14 value is 51.73, suggesting its current momentum. These technical analysis signals help assess ELV's price trends and potential future movements.
Elevance Health Inc. (ELV) stock performance overview as of December 22, 2025: The 52-week high is $458.75 (currently -25.74% below), and the 52-week low is $273.71 (currently 24.47% above). Over the past year, ELV's performance is -10.68%, compared to the S&P 500's 12.87% change.
According to market data, Elevance Health Inc. (ELV) stock's recent performance metrics show that over the last month, ELV is 4.98%, with a Year-to-Date (YTD) performance of -7.65%. Over the past year, the stock has seen a -10.68% change. These figures summarize ELV's price movements across various periods, reflecting its historical returns.
According to current financial data, ELV stock's P/E (TTM) ratio is 13.90, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ELV, including P/S (0.39), P/B (1.75), and P/FCF (20.10), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.